CVE-2025-62575NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database.
Updated under an hour ago ()
Does this affect you?
It affects mirion biodose/nmis. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database. The SQL user account 'nmdbuser' and other created accounts by default have the sysadmin role. This can lead to remote code execution through the use of certain built-in stored procedures.
- CVSS
- 8.8 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-732
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Sep 25, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
mirion biodose/nmis mirion:biodose/nmis | before 23.0 | NVD |
References
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.